How to Verify Medical Device Authenticity Before Purchase

A practical authenticity screening process based on source, identity, packaging, documentation and manufacturer escalation. The purpose is to help teams make a clearer, better documented decision without turning a commercial checklist into a clinical recommendation.

Quick answer

Low price, urgent availability and unfamiliar supply routes can increase the risk of counterfeit, diverted or misrepresented devices. A stronger approach produces a documented verification process that escalates uncertainty before use.

This cluster article supports the broader guide on Medical Device Quality and Compliance: A Buyer Guide. The main search topic for this guide is verify medical device authenticity. Related language includes counterfeit medical devices, medical device verification, authentic medical equipment, but the article uses those terms only where they help the reader rather than repeating them mechanically.

Why this matters

Quality review is not a document collection contest. The strongest file is the one in which every important claim is current, relevant to the exact product and consistent with the label, legal manufacturer, supplier and destination.

For healthcare buyers, quality teams and receiving departments, the practical risk is not limited to price. A wrong reference, incomplete pack, uncertain shelf life, late shipment or unsupported alternative can create rework, unused inventory and avoidable delays. A useful buying process therefore connects the technical request, commercial offer and receiving standard.

The best time to resolve ambiguity is before the purchase order. Once goods are dispatched, every unclear field becomes harder and more expensive to correct. The controls below are designed to move important questions to the beginning of the process.

Key checks

These checks should be adapted to product risk and organisational policy. A routine low risk item and a sterile implantable or procedure critical device should not automatically receive the same depth of review.

A practical workflow

1. Step 1: Assess source and transaction risk before payment. Record the owner, evidence and completion date so the action can be checked later.
2. Step 2: Collect clear product and packaging evidence. Record the owner, evidence and completion date so the action can be checked later.
3. Step 3: Compare identifiers across all records. Record the owner, evidence and completion date so the action can be checked later.
4. Step 4: Check official databases and manufacturer information where applicable. Record the owner, evidence and completion date so the action can be checked later.
5. Step 5: Quarantine and escalate unresolved concerns. Record the owner, evidence and completion date so the action can be checked later.
6. Step 6: Record the decision and preserve evidence. Record the owner, evidence and completion date so the action can be checked later.

A workflow is only useful when exceptions are visible. If a field is unknown, mark it as unknown and assign an owner. Do not fill the gap with an assumption merely to complete the form. The decision record should show what was confirmed, what remained conditional and which stakeholder accepted the residual risk.

Documentation and verification

Official databases, manufacturer channels and verifiable certification information should be used according to risk. A buyer should record the source and date of an important check because statuses, certificates and commercial arrangements can change.

Receiving, quarantine, complaints and recalls form part of procurement quality. Evidence should remain connected from the approved quotation through delivery, storage and final disposition so that an investigation can be completed without rebuilding the history.

For every important document, record the document title, issuing organisation, product or company scope, version or validity date, source and date reviewed. This simple index helps prevent a valid document from being attached to the wrong product or reused after it becomes outdated.

Minimum decision record

• The original request and clinician or technical approval where required
• The exact quoted product identity, pack and quantity
• Supplier assumptions, deviations and proposed alternatives
• Quality, regulatory and traceability evidence proportionate to risk
• Price basis, landed cost assumptions, lead time and shelf life
• Approval names, dates and any conditions
• Receiving checks and final disposition of discrepancies

Questions to ask before approval

• Can the supplier demonstrate the source trail described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the label identity described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the packaging quality described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the document verification described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the manufacturer contact described in the RFQ, and can the answer be connected to the exact quoted product?

Ask suppliers to answer against each RFQ line rather than in a general email. A line level response makes it easier to compare offers, detect partial matches and transfer the approved information into the purchase order.

Common mistakes

• Treating a low price as proof of counterfeit or authenticity. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Relying on a barcode scan without checking the full label. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Contacting the manufacturer through details supplied only by the seller. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Destroying suspicious packaging before the investigation is complete. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.

Most procurement errors are not caused by one dramatic failure. They develop through several small gaps, such as an abbreviated name, an unrecorded assumption and a receiving check that compares quantity but not reference. Closing those gaps consistently is more effective than adding a large document request after a problem occurs.

Practical example

The lesson is not that every enquiry must become slow. A structured template is usually faster because it reduces repeated emails and makes approval requirements visible from the start.

Final checklist

• ✓ Source trail has been reviewed: Identify the seller, invoicing entity and upstream source information available for the transaction.
• ✓ Label identity has been reviewed: Compare legal manufacturer, product name, reference, lot, expiry and UDI where applicable.
• ✓ Packaging quality has been reviewed: Inspect print, seals, materials and tamper evidence against reliable samples or manufacturer guidance.
• ✓ Document verification has been reviewed: Check that certificates and declarations are current and relevant to the exact product.
• ✓ Manufacturer contact has been reviewed: Use official contact routes when doubt remains.

Before closing the file, confirm that the purchase order reflects the approved quotation rather than an earlier draft. At receiving, compare the physical label and condition with the same approved record. This completes the link between request, order and delivered product.

Frequently asked questions

Related AJA guides

• Medical Device Quality and Compliance: A Buyer GuideA buyer framework for product identity, supplier evidence, regulatory status, packaging, traceability and issue escalation.
• CE Marking, FDA Status and UAE Registration: What Buyers Should CheckA plain language comparison of different market status signals and why none should be used as a universal shortcut.
• ISO 13485 Explained for Medical Device BuyersA buyer focused explanation of what ISO 13485 certification can indicate, what it does not prove and how to review certificate scope.
• Sterile Packaging Integrity: Inspection Checklist for Receiving TeamsA practical receiving checklist for seals, punctures, moisture, labels, crushing and quarantine decisions.

Browse the medical device product catalogue, review the brand sourcing profiles or read about AJA International’s quality and compliance approach.

Official resources and further reading

• FDA Quality Management System Regulation
• FDA Unique Device Identification system
• European Commission medical devices sector

Editorial review: Prepared for publication in 2026. Regulatory, registration and product information can change, so readers should confirm current requirements and manufacturer documentation before acting.